Alzheimer’s Disease Outline
Alzheimer’s Disease Outline
Alzheimer’s disease is a progressive disease the results from impaired or damaged brain cells which leads to different extremes of dementia. Alzheimer’s is a progressive disease, where dementia symptoms gradually worsen over several years. In its early stages, memory loss is mild, but with late-stage Alzheimer’s, individuals lose the ability to carry on a conversation and respond to the environment around them. In this summary, our team explains the overview of Alzheimer’s disease. Our team will also describe the demographics of the clientele and the possible health promotion idea.
- Alzheimer’s disease-
- A form of dementia which is common amongst older people. Dementia is a name for symptoms that are affected by the brain such as not being able to think good enough to do normal activities.
- Alzheimer’s disease begins slowly at first. It attacks specific parts of the brain such as memory, thought, and language. Older people who are experiencing Alzheimer’s disease may forget names and faces.
- Over time, Alzheimer’s disease gets worse. People may forget who their family members and friends are. Families may experience their loved one who suffers from this disease, to be called by someone else’s name. This kind of memory loss happens when this disease is not controllable.
- Some other examples are having trouble speaking, writing, and reading. People, who have Alzheimer’s, have a hard time getting daily routines done. Some of those routines include brushing their teeth and combing their hair.
- Further progression of this disease can cause patients to be more aggressive and do things out of character such as wandering around. Alzheimer’s disease usually happens after age 60. There is no treatment, and the risks are high when you have a family member with the disease.
- Some medications can help reduce memory loss, but it will only last for a limited time. People with Alzheimer’s disease need full-time care, and it can bring less stress to the families and friends if the patient gets proper treatment in a facility.
- According to the Alzheimer’s Association, there are 5.7 million American’s who have this disease. There are 1 in 10 people over the age of 65 and older (Facts and Figures, 2018).
- This disease affects more women than men.
- African-Americans are two times more likely to have a form of Alzheimer’s than Caucasians. Hispanics are 1 to 1.5 times more likely to have a form of Alzheimer’s than Caucasians.
- The rate of death has increased by 123% from 2000-2015. It is the only top 10 cause of death in the US that is not preventable or slowed down. It is the 6th leading cause of death in the US and the 5th leading cause of death amongst those who are 65 and older.
- Possible health promotion idea
- Although popular medications cannot remedy Alzheimer’s or stop it from advancing, they may help decrease symptoms, such as memory loss and disorientation, for a short time.
- In the brain, neurons connect and interact at synapses, where tiny explosions of chemicals called neurotransmitters move data from one cell to another. Alzheimer’s obstructs this method, and ultimately kills synapses and kills neurons, destroying the brain’s interaction system.
- Early diagnosis-
- Developments of biomarkers are making it easier to diagnose and care for those who have/will have Alzheimer’s. Early diagnosis also allows the patient to plan to make the appropriate arrangements.
- Medications –
- The United States Food and Drug Administration has authorized two categories of prescriptions cholinesterase inhibitors (Aricept, Exelon, Razadyne) and memantine (Namenda) to administer the cognitive symptoms (memory loss, disorientation, and difficulties with rational and argumentation) of Alzheimer’s disease.
- As Alzheimer’s proceeds, cerebrum cells die, and intermediaries among cells are lost, creating cognitive indications to worsen. While popular prescriptions cannot stop the destruction Alzheimer’s events to brain cells, they may help decrease or sustain signs for an insufficient time by assuming specific substances implicated in transmitting communications among the brain’s tissue cells. Physicians sometimes prescribe both types of medications together.
- All the medicine prescriptions currently licensed to treat Alzheimer’s signs in the beginning to reasonable degrees are from a type of medications called cholinesterase inhibitors. Cholinesterase inhibitors are prearranged to manage warning sign associated with consciousness, reasoning, communication, analysis, and other thought processes. Limit the breakdown of acetylcholine (a-SEA-til-KOH-lean), a biochemical carrier essential for knowledge and remembrance. This promotes communication among tissue cells by blocking acetylcholine high. Delay or slow worsening of signs. Effectiveness varies from person to person. Memantine is assigned to maintain consciousness, attention, understanding, speech and the capability to administer uncomplicated tasks. It can be used alone or with other Alzheimer’s disease therapies remedies.
By now you may have realized that your memory will change as you age. Alzheimer’s disease, affecting millions of older adults, is a degenerative brain disease and the most common form of dementia. There are three main phases of Alzheimer’s: mild, moderate, and severe. Progression of this disease is slow, and symptoms can include the loss of recent memories, confusion, wandering, and extreme mood swings. In the final stages of the disease, the ability to respond to their environment can occur, and eventually the ability to control movement leading to individuals needing extensive help with daily activities and personal care. With approved medications from the FDA, such as cholinesterase inhibitors and memantine, the symptoms of dementia can be slowed down but not cured.